Support for a centralized review board for cancer clinical trials
LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB)
This study is looking at how a central review board can make cancer clinical trials quicker and easier for patients, so they can get access to important treatments faster while still keeping their rights and safety a top priority.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-11212016 on NIH RePORTER |
What this research studies
This research focuses on enhancing the efficiency and ethical oversight of cancer clinical trials through the NCI Central Institutional Review Board (CIRB). By centralizing the review process, the CIRB aims to protect the rights and welfare of participants while reducing the administrative burden on local review boards. This approach allows for faster patient enrollment in clinical trials, ensuring that participants can access potentially life-saving treatments more quickly. The methodology involves collaboration with institutions nationwide to uphold high ethical standards in research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who are considering participation in clinical trials.
Not a fit: Patients who are not eligible for clinical trials or those with conditions outside of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could streamline the process of enrolling patients in cancer clinical trials, leading to quicker access to innovative treatments.
How similar studies have performed: Previous initiatives have shown success in improving the efficiency of clinical trial processes through centralized review systems.
Where this research is happening
Rockville, United States
- The Emmes Company, LLC — Rockville, United States (Active)
Researchers
- Principal investigator: Valmonte, Claudine — The Emmes Company, LLC
- Study coordinator: Valmonte, Claudine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.